News

An AI-supported telemedicine effort from Siloam Vision and Orbis International

In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407

The opportunities and challenges presented by CRISPR manipulation

The European Commission is expected to make a decision about the application before the end of June

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs

AT ELANA 841P from ZEISS is a fully preloaded lens built with leading technologies when it comes to optical performance, biomaterial properties, and IOL design. In this Case of the Month, Dr Luis Fernandez-Vega Cueto-Felgueroso explains why these features motivated him to trial the ZEISS AT ELANA 841P. He also shares his encouraging early outcomes using the AT ELANA 841P that have motivated him to expand its use.

Proteins common to Alzheimer disease play a significant role in glaucoma

Quantitative and qualitative improvement in IOL design

Researchers investigated patients' ability to drive and work following eye injury

Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease

Retina specialists Giuseppe Querques, MD, PhD, and Paolo Lanzetta, MD, debate at the Congress on Controversies in Ophthalmology

At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases

The retina specialist shares advice for the clinician-scientists of a digital-centric future

Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

A longitudinal, AI-based approach to fluid quantification

Mentorship, leadership and addressing bias are key areas for improvement

The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions

Penetrating keratoplasty remains a popular choice for certain patients

The kidney and eye are structurally similar and the diseases of the organs may present via common pathways

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March

Innovative therapies scale up to meet needs of a growing patient population